Pfizer's shares are up 12% this year, while those of its partner BioNTech have soared nearly 300%. This brought the value of the German biotech ...
News
- Pfizer and Moderna could earn $ 32 billion from sales of COVID-19 vaccines
- 'This is our hope and prayer': 28000 COVID-19 vaccines to arrive in SA this week
San Antonio's first week of doses are expected to arrive as soon as Monday ... Several other vaccines are in the works, including one by U.S. biotech ...
- Texas Biomed to test CBD/THC against HIV-induced neurological disorder
San Antonio, Texas (December 11, 2020) - The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators ...
- AstraZeneca buying drug developer Alexion for $39 billion
... Pfizer and Germany's BioNTech that has already earned some emergency approvals, and another by U.S. biotechnology company Moderna.
- BioCryst bags $250M in a debt and royalty deal as the executive team preps a new drug launch for ...
The biotech reported Monday morning that they've inked a deal with ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.